Logo

Asuragen

Asuragen Makes Strides Developing Nanopore Sequencing-Based Carrier Screening Assay
Premium

The company’s research-use-only AmplideX Nanopore Carrier Plus kit can interrogate 11 genes underpinning nine common carrier screening conditions.

Bio-Techne Receives IVDR Certification for Chronic Myeloid Leukemia Test

The qPCR-based test quantifies BCR-ABL1 and ABL1 transcripts in blood samples from patients with chronic myeloid leukemia to determine their response to treatment.

Oxford Nanopore Technologies, Bio-Techne Partner to Develop Carrier Screening Assay

The project will leverage Asuragen's long-range PCR and Oxford Nanopore's sequencing capabilities to develop a sequencing workflow for carrier screening.

Thermo Fisher Scientific Deal Expands Possibilities for Exosome Dx Business, Bio-Techne CEO Says
Premium

The deal with Thermo Fisher is for the development of Bio-Techne's second test in its Exosome Diagnostics portfolio, a multigene assay for kidney transplant rejection.

In Brief This Week: Bio-Techne, Dante Labs, Metagenomi, Applied DNA Sciences, Caris Life Sciences

News items for the week of April 5, 2021.

Mar 17, 2021

Bio-Techne Seeks to Build Out 'Substantial Diagnostics Presence' With Asuragen Buy
Premium

Mar 3, 2021

Bio-Techne to Acquire Molecular Diagnostics Firm Asuragen for up to $320M

Aug 3, 2020

Pacific Biosciences, Asuragen Collaborate on Clinical Assays

Jul 7, 2020

Asuragen Receives CE Mark for Spinal Muscular Atrophy Assay

Feb 23, 2020

Asuragen Fragile X Diagnostic Test Gets FDA Authorization

Nov 25, 2019

Asuragen, Wave Life Sciences to Develop Companion Diagnostics for Huntington's Disease Therapies

Dec 4, 2018

Asuragen Myotonic Dystrophy 1 Dx Kit Receives CE Mark

Nov 13, 2018

Health Canada Approves Two BCR-ABL Tests

Oct 22, 2018

Asuragen, RTI Collaborate on Fragile X Syndrome Testing

Oct 19, 2018

People in the News: Mary Padbury, Katherine Bach Kalin, Daniel Kolk, More

Sep 7, 2018

Asuragen ALS, Dementia Assay Gets Favorable Evaluation From UPenn Team
Premium

Sep 7, 2018

New Products Posted to GenomeWeb: Genoptix, Asuragen

Sep 5, 2018

Asuragen Gets CE Mark for QuantideX NGS Oncology Panel

Jul 27, 2018

New Products Posted to GenomeWeb: SeraCare, Asuragen, Biofortuna, More

Jun 1, 2018

New Products Posted to GenomeWeb: PerkinElmer, Phase Genomics, Pacific Biosciences, Asuragen, More

Jan 17, 2018

Asuragen Gets CE Mark for QuantideX BCR-ABL Kits on Roche Platform

Feb 21, 2017

Asuragen to Develop IVD Kits on Thermo Fisher Scientific's CE Platform

Dec 12, 2016

Asuragen Research Correlates FMR1 Methylation, Symptoms in Fragile X-Associated Motor Disorder
Premium

Jul 25, 2016

Asuragen BCR-ABL Kit Granted FDA Premarket Clearance

May 19, 2016

Surgical Decisions for Thyroid Nodules Often Not Affected By Molecular Testing